Aileron Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALRN and other ETFs, options, and stocks.

About ALRN

Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. 

CEO
Brian J. Windsor
CEOBrian J. Windsor
Employees
15
Employees15
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2001
Founded2001
Employees
15
Employees15

ALRN Key Statistics

Market cap
83.17M
Market cap83.17M
Price-Earnings ratio
-1.46
Price-Earnings ratio-1.46
Dividend yield
—
Dividend yield—
Average volume
243.76K
Average volume243.76K
High today
$4.99
High today$4.99
Low today
$4.65
Low today$4.65
Open price
$4.88
Open price$4.88
Volume
102.20K
Volume102.20K
52 Week high
$7.42
52 Week high$7.42
52 Week low
$1.01
52 Week low$1.01
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.